Kinvan Private Limited has commenced the production of clavulanic acid, an essential compound used in treating bacterial infections. The company is currently producing small batches and aims to ramp up to full-scale production by the end of 2024, targeting an annual output of 300 metric tons. Kinvan plans to invest ?447.17 crore to establish a facility capable of meeting this production capacity.
*Image used, if any, in this post is for illustration only
Note: The above-mentioned news was first published by us in our ProjectX India | 1st October 2024 edition.. Get this issue or any of our editions by clicking here…
Access Drugs/Pharma sector projects, news, contracts and tenders in ProjectX India PDF edition
ProjectX India helps you identify new projects in India. Accelerate your business by getting timely information on upcoming and ongoing projects, contract awards, and tenders. ProjectX India provides you with actionable new project opportunities through contacts. The copy is delivered to you through email every fortnight. For subscriptions, click here…
Click here to download an evaluation copy that covers new projects from India, ongoing projects from India, contract awards from India, and public procurement opportunities from India. WhatsApp us at 877 927 9155 for subscriptions or advertising on this website and digital edition.